Glucose control in the hospitalized elderly -a concern not just for patients with diabetes

Geriatrics

Volumn 64, Issue 6, 2009, Pages

  Szerszen, Anita ^a   Seminara, Donna P ^a   Castellanos, Mario R ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

Glucose control; Hyperglycemia; Morbidity; Mortality

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; GLUCOSE; INSULIN;

AGED; AGED HOSPITAL PATIENT; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; EVIDENCE BASED PRACTICE; FASTING BLOOD GLUCOSE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; RISK FACTOR; SCREENING TEST; SEPSIS; SHORT SURVEY; ARTICLE; BLOOD; CRITICAL ILLNESS; IMMUNOLOGY;

AGED; BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA;

EID: 69849089737     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undi-agnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.
2. Christiansen C, Toft P, Jorgensen HS, et al. Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med. 2004;30(8):1685-1688.
3. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624-1633.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
5. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-1021.
6. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426-2432.
7. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-778.
8. Turina M, Miller FN, Tucker C, Polk HC. Effects of hyperglycemia, hyperinsulinemia, and hyperosmolarity on neutrophil apoptosis. Surg Infect. 2006;7(2):111-121.
9. Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Iinfect Dis. 2005;40(7):990-996.
10. Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3-4):259-265.
11. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26(2):510-513.
12. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am. 2001;15(27):407-421.
13. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22(2):77-81.
14. Chan ED, Welsh CH. Geriatric respiratory medicine. Chest. 1998;114(6):1704-1733.
15. Dorken E, Grzybowski S, Allen EA. Significance of the tuberculin test in the elderly. Chest. 1987;92(2):237-240.
16. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32(suppl):S13-S61.
17. Krinsley J. Glycemic control in critically ill patients: Leuven and beyond. Chest. 2007;132(1):1-2.
18. Preiser J, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med. 2007;3(9suppl): S503-S507.
19. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-138.
20. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565-1572.
21. NICE-SUGAR Study Investigators, Finfer S, Chittock, DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.
22. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-944 22.
23. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-827.
24. McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810-818.
25. Khalfin A, Saifan C, Ahmed A, et al. Effects of impaired fasting glucose (IFG) on pneumonia outcomes. Poster presented at: American Association of Clinical Endocrinologists 16th Annual Meeting and Clinical Congress [abstract 201]; April 11-15, 2007; Seattle, WA.
26. Bruno A, Gregori D, Caropreso A, et al. Normal glucose values are associated with a lower risk of mortality in hospitalized patients. Diabetes Care. 2008; 31(4):2209-2210.
27. Nagamine M, Jiang HJ, Merill CT. Trends in elderly hospitalizations, 1997-2004. October 2006. www.hcup-us.ahrq.gov/reports/statbriefs/ sb14.pdf. Accessed May 19, 2009.